- Home
- CFSB vs CELU Comparison
CFSB vs CELU Comparison
Compare CFSB & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFSB
- CELU
- Stock Information
- Founded
- CFSB 1889
- CELU 2016
- Country
- CFSB United States
- CELU United States
- Employees
- CFSB N/A
- CELU N/A
- Industry
- CFSB Major Banks
- CELU Biotechnology: Pharmaceutical Preparations
- Sector
- CFSB Finance
- CELU Health Care
- Exchange
- CFSB Nasdaq
- CELU Nasdaq
- Market Cap
- CFSB 51.6M
- CELU 49.8M
- IPO Year
- CFSB N/A
- CELU N/A
- Fundamental
- Price
- CFSB $13.65
- CELU $1.75
- Analyst Decision
- CFSB
- CELU
- Analyst Count
- CFSB 0
- CELU 0
- Target Price
- CFSB N/A
- CELU N/A
- AVG Volume (30 Days)
- CFSB 32.5K
- CELU 73.3K
- Earning Date
- CFSB 07-29-2025
- CELU 05-08-2025
- Dividend Yield
- CFSB N/A
- CELU N/A
- EPS Growth
- CFSB N/A
- CELU N/A
- EPS
- CFSB N/A
- CELU N/A
- Revenue
- CFSB $7,484,000.00
- CELU $54,220,000.00
- Revenue This Year
- CFSB N/A
- CELU $23.29
- Revenue Next Year
- CFSB N/A
- CELU N/A
- P/E Ratio
- CFSB N/A
- CELU N/A
- Revenue Growth
- CFSB N/A
- CELU 138.11
- 52 Week Low
- CFSB $6.34
- CELU $1.00
- 52 Week High
- CFSB $13.78
- CELU $5.22
- Technical
- Relative Strength Index (RSI)
- CFSB 89.37
- CELU 42.55
- Support Level
- CFSB $13.60
- CELU $1.78
- Resistance Level
- CFSB $13.70
- CELU $2.10
- Average True Range (ATR)
- CFSB 0.04
- CELU 0.19
- MACD
- CFSB -0.12
- CELU -0.07
- Stochastic Oscillator
- CFSB 61.54
- CELU 4.00
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.